LEMAITRE VASCULAR INC (LMAT) Fundamental Analysis & Valuation

NASDAQ:LMAT • US5255582018

Current stock price

114.81 USD
-2.58 (-2.2%)
At close:
114.81 USD
0 (0%)
After Hours:

This LMAT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. LMAT Profitability Analysis

1.1 Basic Checks

  • LMAT had positive earnings in the past year.
  • LMAT had a positive operating cash flow in the past year.
  • In the past 5 years LMAT has always been profitable.
  • LMAT had a positive operating cash flow in each of the past 5 years.
LMAT Yearly Net Income VS EBIT VS OCF VS FCFLMAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

1.2 Ratios

  • With an excellent Return On Assets value of 9.38%, LMAT belongs to the best of the industry, outperforming 89.36% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 14.67%, LMAT belongs to the top of the industry, outperforming 89.36% of the companies in the same industry.
  • LMAT has a better Return On Invested Capital (9.04%) than 87.23% of its industry peers.
  • LMAT had an Average Return On Invested Capital over the past 3 years of 8.61%. This is in line with the industry average of 9.15%.
  • The 3 year average ROIC (8.61%) for LMAT is below the current ROIC(9.04%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.38%
ROE 14.67%
ROIC 9.04%
ROA(3y)8.68%
ROA(5y)8.37%
ROE(3y)12.61%
ROE(5y)11.22%
ROIC(3y)8.61%
ROIC(5y)8.85%
LMAT Yearly ROA, ROE, ROICLMAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 23.13%, LMAT belongs to the top of the industry, outperforming 94.68% of the companies in the same industry.
  • In the last couple of years the Profit Margin of LMAT has grown nicely.
  • The Operating Margin of LMAT (27.21%) is better than 96.28% of its industry peers.
  • LMAT's Operating Margin has improved in the last couple of years.
  • The Gross Margin of LMAT (71.53%) is better than 81.38% of its industry peers.
  • In the last couple of years the Gross Margin of LMAT has grown nicely.
Industry RankSector Rank
OM 27.21%
PM (TTM) 23.13%
GM 71.53%
OM growth 3Y13.74%
OM growth 5Y4.46%
PM growth 3Y22%
PM growth 5Y7.14%
GM growth 3Y3.31%
GM growth 5Y1.81%
LMAT Yearly Profit, Operating, Gross MarginsLMAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. LMAT Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), LMAT is creating some value.
  • Compared to 1 year ago, LMAT has more shares outstanding
  • Compared to 5 years ago, LMAT has more shares outstanding
  • LMAT has a better debt/assets ratio than last year.
LMAT Yearly Shares OutstandingLMAT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
LMAT Yearly Total Debt VS Total AssetsLMAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 9.25 indicates that LMAT is not in any danger for bankruptcy at the moment.
  • LMAT has a better Altman-Z score (9.25) than 86.70% of its industry peers.
  • The Debt to FCF ratio of LMAT is 2.26, which is a good value as it means it would take LMAT, 2.26 years of fcf income to pay off all of its debts.
  • LMAT has a better Debt to FCF ratio (2.26) than 85.11% of its industry peers.
  • LMAT has a Debt/Equity ratio of 0.43. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.43, LMAT is in line with its industry, outperforming 44.15% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 2.26
Altman-Z 9.25
ROIC/WACC1.05
WACC8.6%
LMAT Yearly LT Debt VS Equity VS FCFLMAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.3 Liquidity

  • LMAT has a Current Ratio of 12.89. This indicates that LMAT is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of LMAT (12.89) is better than 97.87% of its industry peers.
  • LMAT has a Quick Ratio of 10.95. This indicates that LMAT is financially healthy and has no problem in meeting its short term obligations.
  • LMAT has a Quick ratio of 10.95. This is amongst the best in the industry. LMAT outperforms 97.34% of its industry peers.
Industry RankSector Rank
Current Ratio 12.89
Quick Ratio 10.95
LMAT Yearly Current Assets VS Current LiabilitesLMAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. LMAT Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 22.68% over the past year.
  • Measured over the past years, LMAT shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.12% on average per year.
  • LMAT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.53%.
  • LMAT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.04% yearly.
EPS 1Y (TTM)22.68%
EPS 3Y36.78%
EPS 5Y17.12%
EPS Q2Q%38.78%
Revenue 1Y (TTM)13.53%
Revenue growth 3Y15.57%
Revenue growth 5Y14.04%
Sales Q2Q%15.68%

3.2 Future

  • Based on estimates for the next years, LMAT will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.37% on average per year.
  • Based on estimates for the next years, LMAT will show a quite strong growth in Revenue. The Revenue will grow by 9.67% on average per year.
EPS Next Y24.41%
EPS Next 2Y16.72%
EPS Next 3Y12.89%
EPS Next 5Y11.37%
Revenue Next Year12.71%
Revenue Next 2Y10.78%
Revenue Next 3Y10.08%
Revenue Next 5Y9.67%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LMAT Yearly Revenue VS EstimatesLMAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M
LMAT Yearly EPS VS EstimatesLMAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

4

4. LMAT Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 48.24, the valuation of LMAT can be described as expensive.
  • Based on the Price/Earnings ratio, LMAT is valued a bit cheaper than the industry average as 66.49% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 27.38. LMAT is valued rather expensively when compared to this.
  • Based on the Price/Forward Earnings ratio of 38.77, the valuation of LMAT can be described as expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of LMAT indicates a somewhat cheap valuation: LMAT is cheaper than 70.21% of the companies listed in the same industry.
  • LMAT's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 38.20.
Industry RankSector Rank
PE 48.24
Fwd PE 38.77
LMAT Price Earnings VS Forward Price EarningsLMAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, LMAT is valued a bit cheaper than the industry average as 70.21% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, LMAT is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 35.12
EV/EBITDA 27.48
LMAT Per share dataLMAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates LMAT does not grow enough to justify the current Price/Earnings ratio.
  • LMAT has an outstanding profitability rating, which may justify a higher PE ratio.
  • LMAT's earnings are expected to grow with 12.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.98
PEG (5Y)2.82
EPS Next 2Y16.72%
EPS Next 3Y12.89%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. LMAT Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.89%, LMAT is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.24, LMAT pays a better dividend. On top of this LMAT pays more dividend than 91.49% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, LMAT's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.89%

5.2 History

  • The dividend of LMAT is nicely growing with an annual growth rate of 16.13%!
  • LMAT has been paying a dividend for at least 10 years, so it has a reliable track record.
  • LMAT has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)16.13%
Div Incr Years14
Div Non Decr Years14
LMAT Yearly Dividends per shareLMAT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

5.3 Sustainability

  • 31.37% of the earnings are spent on dividend by LMAT. This is a low number and sustainable payout ratio.
  • The dividend of LMAT is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP31.37%
EPS Next 2Y16.72%
EPS Next 3Y12.89%
LMAT Yearly Income VS Free CF VS DividendLMAT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
LMAT Dividend Payout.LMAT Dividend Payout, showing the Payout Ratio.LMAT Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

LMAT Fundamentals: All Metrics, Ratios and Statistics

LEMAITRE VASCULAR INC

NASDAQ:LMAT (4/15/2026, 8:02:31 PM)

After market: 114.81 0 (0%)

114.81

-2.58 (-2.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-25
Earnings (Next)04-30
Inst Owners95.94%
Inst Owner Change0.06%
Ins Owners7.04%
Ins Owner Change-9.98%
Market Cap2.62B
Revenue(TTM)249.60M
Net Income(TTM)57.73M
Analysts80
Price Target113.07 (-1.52%)
Short Float %6.3%
Short Ratio5.67
Dividend
Industry RankSector Rank
Dividend Yield 0.89%
Yearly Dividend0.8
Dividend Growth(5Y)16.13%
DP31.37%
Div Incr Years14
Div Non Decr Years14
Ex-Date03-12
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.9%
Min EPS beat(2)0.42%
Max EPS beat(2)7.38%
EPS beat(4)3
Avg EPS beat(4)1.52%
Min EPS beat(4)-5.52%
Max EPS beat(4)7.38%
EPS beat(8)6
Avg EPS beat(8)4.19%
EPS beat(12)10
Avg EPS beat(12)5.13%
EPS beat(16)10
Avg EPS beat(16)-0.04%
Revenue beat(2)1
Avg Revenue beat(2)-1.58%
Min Revenue beat(2)-3.74%
Max Revenue beat(2)0.58%
Revenue beat(4)3
Avg Revenue beat(4)-0.13%
Min Revenue beat(4)-3.74%
Max Revenue beat(4)1.83%
Revenue beat(8)5
Avg Revenue beat(8)-0.14%
Revenue beat(12)7
Avg Revenue beat(12)0.21%
Revenue beat(16)8
Avg Revenue beat(16)-0.25%
PT rev (1m)6.94%
PT rev (3m)6.94%
EPS NQ rev (1m)0.15%
EPS NQ rev (3m)7.26%
EPS NY rev (1m)2.94%
EPS NY rev (3m)12.21%
Revenue NQ rev (1m)0.18%
Revenue NQ rev (3m)1.1%
Revenue NY rev (1m)0.49%
Revenue NY rev (3m)3.22%
Valuation
Industry RankSector Rank
PE 48.24
Fwd PE 38.77
P/S 10.48
P/FCF 35.12
P/OCF 32.19
P/B 6.65
P/tB 8.88
EV/EBITDA 27.48
EPS(TTM)2.38
EY2.07%
EPS(NY)2.96
Fwd EY2.58%
FCF(TTM)3.27
FCFY2.85%
OCF(TTM)3.57
OCFY3.11%
SpS10.96
BVpS17.27
TBVpS12.93
PEG (NY)1.98
PEG (5Y)2.82
Graham Number30.4147 (-73.51%)
Profitability
Industry RankSector Rank
ROA 9.38%
ROE 14.67%
ROCE 11.72%
ROIC 9.04%
ROICexc 23.78%
ROICexgc 43.2%
OM 27.21%
PM (TTM) 23.13%
GM 71.53%
FCFM 29.83%
ROA(3y)8.68%
ROA(5y)8.37%
ROE(3y)12.61%
ROE(5y)11.22%
ROIC(3y)8.61%
ROIC(5y)8.85%
ROICexc(3y)18.5%
ROICexc(5y)16.17%
ROICexgc(3y)34.8%
ROICexgc(5y)32.81%
ROCE(3y)11.16%
ROCE(5y)11.48%
ROICexgc growth 3Y19.07%
ROICexgc growth 5Y8.49%
ROICexc growth 3Y27.82%
ROICexc growth 5Y16.94%
OM growth 3Y13.74%
OM growth 5Y4.46%
PM growth 3Y22%
PM growth 5Y7.14%
GM growth 3Y3.31%
GM growth 5Y1.81%
F-Score7
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 2.26
Debt/EBITDA 2.15
Cap/Depr 65.11%
Cap/Sales 2.72%
Interest Coverage 250
Cash Conversion 103.73%
Profit Quality 128.99%
Current Ratio 12.89
Quick Ratio 10.95
Altman-Z 9.25
F-Score7
WACC8.6%
ROIC/WACC1.05
Cap/Depr(3y)71.15%
Cap/Depr(5y)58.36%
Cap/Sales(3y)3.21%
Cap/Sales(5y)2.96%
Profit Quality(3y)103.77%
Profit Quality(5y)106.24%
High Growth Momentum
Growth
EPS 1Y (TTM)22.68%
EPS 3Y36.78%
EPS 5Y17.12%
EPS Q2Q%38.78%
EPS Next Y24.41%
EPS Next 2Y16.72%
EPS Next 3Y12.89%
EPS Next 5Y11.37%
Revenue 1Y (TTM)13.53%
Revenue growth 3Y15.57%
Revenue growth 5Y14.04%
Sales Q2Q%15.68%
Revenue Next Year12.71%
Revenue Next 2Y10.78%
Revenue Next 3Y10.08%
Revenue Next 5Y9.67%
EBIT growth 1Y29.96%
EBIT growth 3Y31.45%
EBIT growth 5Y19.13%
EBIT Next Year39.22%
EBIT Next 3Y19.89%
EBIT Next 5Y16.94%
FCF growth 1Y100.39%
FCF growth 3Y49.81%
FCF growth 5Y18.54%
OCF growth 1Y84.14%
OCF growth 3Y47.38%
OCF growth 5Y18.48%

LEMAITRE VASCULAR INC / LMAT Fundamental Analysis FAQ

What is the ChartMill fundamental rating of LEMAITRE VASCULAR INC (LMAT) stock?

ChartMill assigns a fundamental rating of 7 / 10 to LMAT.


What is the valuation status of LEMAITRE VASCULAR INC (LMAT) stock?

ChartMill assigns a valuation rating of 4 / 10 to LEMAITRE VASCULAR INC (LMAT). This can be considered as Fairly Valued.


Can you provide the profitability details for LEMAITRE VASCULAR INC?

LEMAITRE VASCULAR INC (LMAT) has a profitability rating of 9 / 10.


What is the expected EPS growth for LEMAITRE VASCULAR INC (LMAT) stock?

The Earnings per Share (EPS) of LEMAITRE VASCULAR INC (LMAT) is expected to grow by 24.41% in the next year.


Can you provide the dividend sustainability for LMAT stock?

The dividend rating of LEMAITRE VASCULAR INC (LMAT) is 6 / 10 and the dividend payout ratio is 31.37%.